Login / Signup

Does enzalutamide related PSMA upregulation affect outcomes of lutetium-177 PSMA radioligand therapy?

Turgut Bora CengizRaksha KulkarniMatteo NovelloAnthony HafezSomali GavaneMunir GhesaniNasrin Ghesani
Published in: Urologia (2024)
Enzalutamide treatment prior to Lu-PSMA does not improve patient outcomes when applied remotely. Larger studies evaluating the combination therapies and the timing of enzalutamide are needed to assess its correlation with Lu-PSMA outcomes.
Keyphrases
  • pet ct
  • prostate cancer
  • pet imaging
  • positron emission tomography
  • type diabetes
  • combination therapy
  • skeletal muscle
  • replacement therapy
  • long non coding rna
  • smoking cessation